Rachel K. King

2017

In 2017, Rachel K. King earned a total compensation of $1.6M as President and Chief Executive Officer at GlycoMimetics, a 26% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$301,500
Option Awards$747,250
Salary$502,500
Other$4,050
Total$1,555,300

King received $747.3K in option awards, accounting for 48% of the total pay in 2017.

King also received $301.5K in non-equity incentive plan, $502.5K in salary and $4.1K in other compensation.

Rankings

In 2017, Rachel K. King's compensation ranked 6,791st out of 14,666 executives tracked by ExecPay. In other words, King earned more than 53.7% of executives.

ClassificationRankingPercentile
All
6,791
out of 14,666
54th
Division
Manufacturing
2,518
out of 5,772
56th
Major group
Chemicals And Allied Products
813
out of 2,075
61st
Industry group
Drugs
628
out of 1,731
64th
Industry
Pharmaceutical Preparations
495
out of 1,333
63rd
Source: SEC filing on April 13, 2018.

King's colleagues

We found three more compensation records of executives who worked with Rachel K. King at GlycoMimetics in 2017.

2017

Helen Thackray

GlycoMimetics

Chief Medical Officer

2017

John Magnani

GlycoMimetics

Chief Scientific Officer

2017

Brian Hahn

GlycoMimetics

Chief Financial Officer

News

You may also like